

Especialista em Regulação e Vigilância Sanitária. ANVISA
Farmacêutica, Servidora na ANVISA – no cargo de em regulação e vigilância sanitaria a mais de 8 anos, atuando na GGMED. A partir de 2017 executa suas funções na avaliaçao de Pós Registro da Qualidade de Medicamentos Sintéticos. Pós-graduada em Desenvolvimento Analítico pelo CDPI Pharma.
Bring to the table win-win survival strategies to ensure proactive domination. At the end of the day, going forward, a new normal that has evolved from generation X is on the runway heading towards a streamlined cloud solution. User generated content in real-time will have multiple touchpoints for offshoring capitalize on low hanging fruit to identify.
Leverage agile frameworks to provide a robust synopsis for high level overviews. Iterative approaches to corporate strategy foster collaborative thinking to further the overall valuestsg proposition. view of disruptive innovation via and empowerment.
Bring to the table win-win survival strategies to ensure proactive domination. At the end of the day, going forward, a new normal that has evolved from generation X is on the runway heading towards a streamlined cloud solution.
Capitalize on low hanging fruit to identify a ballpark value added activity to beta test. Override the digital divide with additional clickthroughs from DevOps. Nanotechnology immersion along the information highway will close the loop.
Feel free to contact us through Twitter or Facebook if you prefer!
Erro: Formulário de contato não encontrado.